Luminescent conjugates between dinuclear rhenium complexes and 17&#945;-ethynylestradiol: synthesis, photophysical characterization, and cell imaging by M. Proverbio et al.
This is an Accepted Manuscript, which has been through the  
Royal Society of Chemistry peer review process and has been 
accepted for publication.
Accepted Manuscripts are published online shortly after 
acceptance, before technical editing, formatting and proof reading. 
Using this free service, authors can make their results available 
to the community, in citable form, before we publish the edited 
article. We will replace this Accepted Manuscript with the edited 
and formatted Advance Article as soon as it is available.
You can find more information about Accepted Manuscripts in the 
author guidelines.
Please note that technical editing may introduce minor changes 
to the text and/or graphics, which may alter content. The journal’s 
standard Terms & Conditions and the ethical guidelines, outlined 
in our author and reviewer resource centre, still apply. In no 
event shall the Royal Society of Chemistry be held responsible 
for any errors or omissions in this Accepted Manuscript or any 
consequences arising from the use of any information it contains. 
Accepted Manuscript
rsc.li/obc
Organic &
 Biomolecular 
Chemistry
www.rsc.org/obc
ISSN 1477-0520
COMMUNICATION
Takeharu Haino et al.
Solvent-induced emission of organogels based on tris(phenylisoxazolyl)
benzene
Volume 14 Number 1 7 January 2016 Pages 1–372
Organic &
 Biomolecular 
Chemistry
View Article Online
View Journal
This article can be cited before page numbers have been issued, to do this please use:  M. Proverbio, E.
Quartapelle Procopio, M. Panigati, S. Mercurio, R. Pennati, M. Ascagni, R. Leone, C. A. M. La Porta and M.
Sugni, Org. Biomol. Chem., 2018, DOI: 10.1039/C8OB02472C.
Luminescent conjugates between dinuclear rhenium complexes and 17-
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Three new luminescent conjugates between the dinuclear Rhenium complexes and the estradiol, namely E2-Re, are described. The derivatives have 
the general formula [Re2(μ-Cl)2(CO)6(μ-R-pydz-17-ethynilestradiol)] (R-pydz = functionalized 1,2-pyridazine), where the estradiol moiety is covalently 
bound to the β position of the pyridazine ligand. Different synthetic pathways are investigated, including the inverse-type [4+2] Dies Alder 
cycloaddition reaction between the electron poor 1,2,4,5-tetrazine and the 17α-ethynylestradiol for the synthesis of E2-Re1 The three E2-Re  
conjugates are purified on silica gel and isolated in a spectroscopically pure form with moderate to good yields (28-50%). All the E2-Re conjugates are 
comprehensively characterized from the spectroscopic and photophysical point of view. Cellular internalization experiments on human MCF-7 and 
231 cells are also reported, displaying interesting staining differences depending on the nature of the spacer linking the estradiol unit to the 
organometallic fragment. Furthermore, the suitability of these conjugates to stain also simple multicellular organisms, i.e. Ciona intestinalis embryos 
and larvae at different stages of development is here reported for the first time.  
Introduction  
Estrogens are essential hormones involved in many physiological and pathological (e.g. tumorigenesis) life processes of both adults 
and embryos, where they exert a fundamental role via specific molecular transducers (receptors). The critical importance of these 
hormones is demonstrated by the fact that an impairment of their functioning can cause severe adverse effects to the organism, in 
both humans (such as reduced fertility, carcinogenesis) and wild-life.1 Therefore, the possibility to determine the estrogen receptor 
(ER) content of the cells is essential from different point of view.  
 In the past, the design of probes for these proteins has relied mainly on radioactive estrogen derivatives such as radio-
iodinated derivatives 2 or [F-18]-estrogens.3 99mTc is also a readily available nuclide with highly desirable physical properties.4 Today, 
in most clinical and research studies, ER are detected by immunolabelling (i.e. by means of specific antibodies raised against the 
protein). Although this is certainly a well-established procedure, it can have some limitations such as for example species-specificity 
(i.e. an antibody raised against the human ERs hardly works on wild-life species). Furthermore, immunotechniques can be used only 
on “already known” ER, whereas the discovery and study of novel ER forms both in humans or in other animal species requires the 
use of indirect ligand-based methods, such as E2-labelled probes.5  
 The possibility of using luminescent probes for estradiol-binding proteins has also been explored. In particular a wide range 
of estradiol conjugates containing organic fluorophores have been reported,6 while the use of luminescent organo-transition metal 
complexes has not been completely explored.  Actually only few mononuclear rhenium complexes7 and cyclometalated iridium (III) 
polypyridine estradiol conjugates have been reported,8 despite many of the photophysical properties of luminescent transition metal 
complexes make them good candidates for applications in cell imaging. Indeed, their emission characterized by large Stoke shift and 
long luminescent lifetime, allows differentiating their emission from the autofluorescence of the cell. Moreover, the excited states 
of organometallic complexes are particularly stable toward degradation, hampering the photobleaching and reducing their 
cytotoxicity. Further, different parameters such as charge, size and balance between lipophilicity, and water solubility of the 
complexes can be controlled in order to increase their cellular uptake. Therefore a range of structural analogs can be designed by 
this approach, with not demanding synthetic procedure and with the same photophysical properties, allowing to test the better 
probes.9 
 In this framework, in the last years we have developed a novel family of dinuclear tricarbonyl rhenium(I) derivatives (see 
Chart 1) containing a diazine ligand, which exhibit intense emission (photoluminescence quantum yields up to 0.5) in the range 550–
620 nm, originating from triplet metal-to-ligand-charge transfer excited states 3MLCT.10 Some of them have been successfully used 
as luminescent probe for Peptido Nucleic Acids (PNAs) and tested in cell imaging experiments.11 Moreover, the same complexes have 
been employed as new, simple, chemically robust, and easy-to-synthetize platform for different carbohydrate ligands in order to 
develop novel luminescent glycosylated materials.12 
  
Chart 1 General structure of dinuclear Re(I)-complexes bearing a bridging 1,2-diazine ligands with different alkyl groups (R and R’) 
and two ancillary anionic ligands (X = Cl, Br, I). 
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These interesting results have prompted us to synthetize three luminescent rhenium-estradiol conjugates (see Chart 2) and to test 
their localization inside the MCF-7 cells, which express the estradiol receptor.13 Furthermore, we designed experiments to evaluate, 
for the first time, the suitability of the rhenium conjugates also in simple multicellular organisms, i.e. Ciona intestinalis embryos at 
different stages of development.  
The 17-ethynylestradiol has been selected as reagent for the synthesis of the new ligands, which are able to coordinate the dinuclear 
rhenium complex, giving luminescent estradiol conjugates.  The nature and the length of the linker between the 17-estradiol and 
the luminescent organometallic core, together with the substituents on the diazine ligand, have been varied to tailor the desired 
conjugate properties, especially in terms of photophysical properties. 
 
Chart 2 Molecular structure of the three E2-Re conjugates 
 
Results and discussion 
Synthesis. 
The design of the new Re-estradiol conjugates is based on previous works that clearly demonstrated that the absence of the 17-
hydroxyl substituent considerably reduces any effective binding to the receptor site.14 Therefore, we have chosen to retain the 17-
OH linkage and to bind the organometallic moiety to the 17 position. Moreover, it has been demonstrated that the identity of the 
spacer linking the organometallic fragment to C(17) makes a marked difference, with a significant enhancement of the receptor 
binding affinities (RBA) when a rigid alkyl chain is introduced.15 Then, starting from the hormone precursor the 17α-ethynylestradiol, 
two different synthetic routes have been carried out for the synthesis of the three novel Re-estradiol conjugates. 
In particular, in the case of complex E2-Re1, the estradiol fragment has been directly linked to the pyridazine ring by means of the 
inverse-type [4+2] Dies Alder cycloaddition reaction between the electron poor 1,2,4,5-tetrazine and the 17α-ethynylestradiol with 
N2 loss (see Scheme 1) affording the corresponding 3-(17-estradiol)pyridazine D1. The corresponding dinuclear rhenium conjugate 
E2-Re1 has been obtained by refluxing D1 with two equivalents of Re(CO)5Cl in toluene solution using the method previously 
reported.10a  
 
Scheme 1 Synthetic route of complex E2-Re1 
In the case of conjugates E2-Re2 and E2-Re3, an alkyl spacer has been introduced between the organometallic fragment and the 17-
ethynylestradiol, in order to increase the distance between the Re(I) complex and the 17-OH group, avoiding any steric repulsion 
between this functional group and the carbonyl groups on the two metal centres. For this purpose the 17-ethynylestradiol has been 
previously functionalized with a p-aniline by means a Sonogashira palladium-catalysed coupling reaction, between the 4-iodoaniline 
and the 17-ethynylestradiol, affording the 4-(17-ethynylestradiol)aniline precursor (E0, see Scheme 2).7b 
 
Scheme 2 Synthesis of the 4-(17-Ethynylestradiol)aniline (E0) precursor 
Page 2 of 11Organic & Biomolecular Chemistry
O
rg
an
ic
&
B
io
m
ol
ec
ul
ar
C
he
m
is
tr
y
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
11
 D
ec
em
be
r 2
01
8.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ita
 S
tu
di
 d
i M
ila
no
 o
n 
12
/1
2/
20
18
 9
:4
0:
45
 A
M
. 
View Article Online
DOI: 10.1039/C8OB02472C
Two dinuclear Rhenium complexes Re2 and Re3 (see Scheme 3), containing two different diazine ligands, namely 4-(pyridazin-4-yl)-
butanoic acid (D2, Scheme 3) and 8-(5-methylpyridazin-4-yl)-octanoic acid (D3, Scheme 3), have been prepared following the 
previously reported synthetic method.10a,11a  Exploiting the reactivity of the carboxylic acid, both the complexes were further 
covalently linked to the estradiol precursor E0 through the peptide coupling reaction in the presence of HATU and DIPEA at room 
temperature (see Scheme 4).  
The three conjugates have been purified on silica gel and isolated in a spectroscopically pure form with moderate to good yields (28-
50%). 
 
Scheme 3 Synthesis of the two Re(I) complexes 
 
 
Scheme 4 Synthesis of the Re-conjugates E2-Re2 and E2-Re3 
 
Photophysical Characterization. 
The photophysical properties of the Re-estradiol derivatives E2-Re1 - E2-Re3 and of their parent complexes Re2 and Re3 have been 
studied in diluted (concentration of 1.0 x10-5 M) both de-aerated toluene solutions and air-equilibrated H2O-CH3CN solution at room 
temperature (the data are listed in Table 1). 
At long wavelengths, the electronic absorption spectra of conjugates E2-Re1-E2-Re3 displayed broad absorption band with maxima 
in the range 383–364 nm with a moderate intensity (ε ≈ 0.86–0.95 × 104 M-1 cm-1). Such transition can be assigned to the spin allowed 
d(Re)-*(diazine ring) 1MLCT band as typical of this class of complexes.10  
The charge transfer character of this electronic transition is supported by: a) blue shift of the absorption and a red shift of the emission 
maxima, by increasing solvent polarity; b) modulation effect on the photophysical properties on varying the substituents on the 
diazine ligand. Indeed, complex Re3, and its corresponding estradiol conjugate E2-Re3, featuring an electron-richer diazine ligand,  
containing two alkyl substituents in the  positions, displayed a blue-shifted absorption band, with respect to the mono substituted 
complexes E2-Re1, E2-Re2 and Re2. This is in agreement with the different energy level of the LUMO, mainly localized on the * of 
the pyridazine ligand, which is higher for the di-substituted  pyridazine of Re3 and E2-Re3 than for the mono-alkylated ones. The 
conjugation of the estradiol moiety on the organometallic scaffold does not modify the absorption properties, as previously noted 
for the PNA-conjugates11 and for the glycol-derivatives12  
 
Table 1: Photophysical data for the Re2 and Re3 complexes and their related conjugates E2-Re1, E2-Re2 and E2-Re3 in a de-aerated toluene solution and bin 
air-equilibrated H2O-CH3CN 1:1 solution, at 298 K. 
Compound abs [nm]
a em[nm]
a
 
 a  [s]a kr(10-5)s-1 knr(10-5)s-1 
E2-Re1 383  586 (608)b 0.19 (0.017)b 1.8 (0.280)b 1.05 4.50 
E2-Re2 370  585 (607)b 0.18 (0.012)b 1.7 (0.220)b 1.06 4.82 
E2-Re3 364  558 (580)b 0.40 (0.015)b 3.8 (0.270)b 1.05 1.58 
Re2 370 586 0.12 1.6 0.75 5.50 
Re3 364 555 0.55 4.7 1.17 0.96 
 
Upon excitation in the range 440–450 nm at room temperature, in toluene solution, all the samples showed broad and featureless 
emission in the yellow-green region of the visible spectrum (see Fig. 1), which is assigned to the radiative decay of the 3MLCT excited 
state, in comparison with closely related complexes.10b,11 Similarly to what observed in the absorption spectra, complex Re3 and its 
related steroid-conjugate E2-Re3 displayed remarkably different emission features compared to derivatives E2-Re1, E2-Re2 and the 
precursor Re2. In particular, E2-Re3 and Re3, displayed a hypsochromic shifted emission, characterized by a higher and longer 
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emission lifetimes. These features are in agreement with the presence of two alkyl substituents on the diazine ligand (see Table 1), 
responsible for the shift at higher energy of the 3MLCT excited state. The subsequent increase of the emission quantum yield and of 
the lifetime is in agreement with energy gap law.16  
 
Fig. 1: Normalized emission spectra of Re-estradiol conjugates in de-aerated toluene solution at room temperature 
 
Cell cultures 
After chemical characterization, we moved to investigate the behavior (cell internalization and bio-imaging properties) of the three 
conjugates E2-Re1, E2-Re2 and E2-Re3 in biological systems, namely, simple cell cultures system and complex multicellular organisms.  
As for the former, we performed cellular uptake experiments of the different compounds on human breast carcinoma cell line MCF7.  
These cells are known to be estrogen-sensitive since express high levels of E2 receptors.13 In general, none of the tested compound 
resulted cytotoxic: indeed, at all the tested concentrations/exposure times cells were firmly attached to the substrate and their 
morphology was comparable to the controls (Fig. 2-4, Fig. S2), both these features being indications of their actual viability. As 
depicted in Fig. 2-4, we showed that only the conjugate E2-Re1  was clearly internalized by living MCF7 cells. In order to understand 
the effect of initial concentration of staining complex on the cellular behavior at a specific incubation time, we carried out 
concentration dependent uptake experiments. Fig. 2 shows that conjugate E2-Re1 was uptake when concentrations were higher than 
30 µM and incubation times were at least 60 min. After this threshold, accumulation of the marker was rather similar in the different 
experimental conditions. 
On the contrary, conjugates E2-Re2 and E2-Re3 displayed the general tendency to form aggregates in the culture medium, 
hampering their internalization in the cell. Only at the highest concentration (50 μM) and for short-incubation times (30 min) a partial 
up-take was observed for both compounds (see Fig. 3 and 4). This marked difference in cellular behavior, between the three different 
conjugates, could be related to the nature of the spacer linking the organometallic fragment to the C(17) of the estradiol moiety. In 
particular, these data could be interpreted in terms of (a) the hydrophobic versus hydrophilic character of the diazine substituents; 
(b) the steric bulk and the conformational flexibility of the 17 chain. Indeed, in E2-Re3 the presence of the long alkyl chain allows the 
organometallic fragment to rotate freely around the estradiol moiety, sweeping out a great cone angle and increasing the steric 
hindrance then reducing the cellular uptake.  
Moreover the presence of the methyl substituent in the  position of the diazine ligand of E2-Re3, while increases the lipophilicity of 
the conjugate, reduces the solubility in the cellular medium, affording the precipitation of the complex before the cellular up-take 
occurs. 
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Fig. 2 Merged confocal images (bright field + green fluorescence) of MCF-7cell after addition of the compound E2-Re1 at different concentrations (50 
μM, 30 μM and 10 μM in 1% DMSO containing serum-free EMEM) and different incubation times (30, 60, 120 min). Accumulation inside the cells is 
clearly visible for concentrations higher than 30 μM and incubation time longer than 60 min. a: 10 μM, 30 min; b: 10 μM, 60 min; c: 10 μM, 120 min; 
d: 30 μM, 30 min; e: 30 μM, 60 min; f: 30 μM, 120 min; g: 50 μM, 30 min;   h: 50 μM, 60 min; i: 50 μM, 120 min; 
 
 
Fig. 3 Merged confocal image (bright field + green fluorescence) of MCF-7cell after addition of the compound E2-Re2 at different concentrations (50 
μM, 30 μM and 10 μM in 1% DMSO containing serum-free EMEM) and different incubation times (30, 60, 120 min). A scarce internalization of the 
compound is generally observed (aggregates are visible outside the cells) except for the 50 μM, 30 min condition where a partial accumulation is 
visible within the cells. a: 10 μM, 30 min; b: 10 μM, 60 min; c: 10 μM, 120 min; d: 30 μM, 30 min; e: 30 μM, 60 min; f: 30 μM, 120 min; g: 50 μM, 30 
min;   h: 50 μM, 60 min; i: 50 μM, 120 min; 
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Fig. 4 Merged confocal images (bright field + green fluorescence) of MCF-7cell after addition of the compound E2-Re3 at different concentrations (50 
μM, 30 μM in 1% DMSO containing serum-free EMEM) and different incubation times (30, 60, 120 min). No internalization is observed for 
concentration of 30 μM and at 50 μM only partial up-take is visible at short incubation time (30 min) whereas mainly extracellular aggregates can be 
observed after 60 and 120 min of incubation. a: 30 μM, 30 min; b: 30 μM, 60 min;     c: 30 μM, 120 min; d: 50 μM, 30 min; e: 50 μM, 60 min; f: 50 μM, 
120 min;   
 
Multicellular organism (C. intestinalis embryos) 
Experiments with MCF7 cells allowed selecting the proper compound (E2-Re1) to be tested in multicellular organisms such as C. 
intestinalis embryos. In these organisms, E2-Re1 cellular uptake has been observed at both tested developmental stages. In 76-cell 
stage embryos (Fig. 5), the compound penetrated the cellular membrane of the outer cells, staining their cytoplasm and giving rise 
to intracellular emission centered in the green portion of the visible spectrum, with a slight extent in the red one (Fig. 5B and 5D). No 
intracellular emission light has been observed in the blue region of the visible spectrum (Fig. 5C), thus confirming that the cellular 
emission behavior is very similar to that previously observed from photophysical measurements in solution. At late tailbud stage, E2-
Re1 was slightly distributed in all the embryos. Higher concentrations have been detected in the dorsal ectoderm of both trunk and 
tail, at the level of the developing palps and in a trunk mesenchymal region. As in the previous stage, the fluorescence coming from 
the organometallic probe was detectable in both green (Fig. 6B) and red (Fig. 6D) channels but not in the blue one (Fig. 6C). 
 
Fig. 5 C. intestinalis embryo at 76-cell stage exposed to E2-Re1 for 3 h. A) Bright field; B) green fluorescence; C) blue fluorescence; D) red fluorescence. 
Scale bar = 50 µm. 
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Fig. 6 C. intestinalis embryo at late tailbud stage exposed to E2-Re1 for 3 h. A) Bright field; B) green fluorescence; C) blue fluorescence; D) red 
fluorescence. Scale bar = 50 µm. 
Receptor targeting 
To verify the possible interaction and specificity of the E2-Re1 conjugate (the only conjugate able to efficiently stain the cells) with 
the estradiol receptor targeted “negative control” experiments have been performed. In order to evaluate if the presence of the 
estradiol moiety could mediate the cellular uptake and/or the localization inside the cell, in parallel to E2-Re1 conjugate (Fig.7a), we 
therefore investigated the behavior of estradiol-free rhenium complex [Re2(µ-Cl)2(CO)6(µ-4Me-pydz)] (Re-4Me) (Fig.7b) or the effect 
of an estradiol excess on E2-Re1 up-take in MCF-7 cells (Fig. 7c). In both cases a clear cellular staining was still observable, thus 
suggesting a lack of specificity of the probe and indicating that, as already observed for the other Re-conjugates11,12 the mechanism 
of the up-take is mainly by passive diffusion and only partially, if not, mediated by the presence of the biological moiety and by 
specific interaction with ER. This feature is further confirmed by the up-take experiments performed on the 231 cell lines, which 
express low levels of ER. Figure S1 (see Supporting Information) shows that both the conjugate E2-Re1 and the estradiol-free rhenium 
complex Re-4Me could stain these cells.  
It is interesting to note that, in the case of MCF-7, E2-Re1 was still uptake even in the presence of an excess of estradiol and 
the intensity of its emission was higher than in the absence of free estradiol (see Fig. 7c). This feature, in contrast to that usually 
observed in which the excess of estradiol displaces the probe from the binding with ER, suggests the occurrence of some quenching 
of the dye E2-Re1 by the E2-receptor. Indeed, the observed quenching of the emission should be ascribed to the presence of some 
interaction, such as the hydrogen bond between the hydroxyl in position 3 of the estradiol unit of E2-Re1 and some residues of the 
receptor.17  
 
 
Fig. 7: Complex E2-Re1 stains the positive MCF-7 cells: a) 50 µM of E2-Re1 stains MCF-7 cells for 60 min. (B) 50 µM of florescent estradiol-free rhenium 
complex Re-4Me stains MCF-7 cells. (C) 50 µM of E2-Re1 in the presence of 500 µM of estradiol stains the MCF-7 cells. 
Conclusions 
In summary three new fluorescent estrogen derivatives based on different dinuclear rhenium complexes have been successfully 
synthesized. The organometallic fragments have been covalently bound at the end of a rigid CC ethynyl chain at the 17 position of 
the steroid using different synthetic strategies. These bio-conjugates have been evaluated in terms of their photophysical properties 
and suitability as imaging agent in living cells and in small multicellular organisms.  
Although all the complexes were internalized by cells, even if in different amount, only E2-Re1 provided a reliable bioimaging of 
cellular uptake. The marked differences among the compounds have been mainly ascribed to the nature of the spacer linking the 
organometallic fragment to C(17) of the estradiol, which modulates not only the photophysical properties, but also the interaction 
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between the probes and the cells. Unfortunately, the well-known ability of the dinuclear rhenium fragment to penetrate the cellular 
membranes, which in many cases allowed the cellular uptake of PNA oligomers, here hampers the possibility to exploit them for the 
detection of the estradiol receptor in the cells, thus confirming that parameters like solubility, size and lipophilicity of the probes 
must be controlled very well in order to obtained the best results.  
On the other hand, these experiments have confirmed the previous findings concerning the good uptake and the low 
cytotoxicity of the dinuclear rhenium complexes, thus suggesting their possible future use as probes for imaging application in living 
cell. Therefore we can consider this work a preliminary study aimed to find the better probe, in a range of structural analogs and with 
the same photophysical properties, in terms of emission intensity, stability, cytotoxity and  cell uptake. Future work is planned to 
modify this molecular structure in order to increase the solubility in water and reduce the lipophilicity of the complex (and the use 
of DMSO in the cellular uptake) with the aim to make the internalization process more specific and selective. Experiments to better 
evaluate the binding with the estradiol receptor are also planned. 
Finally, preliminary confocal emission imaging of the multicellular organism with the best performing dye E2-Re1 have been also 
obtained. To the best of our knowledge, this is the first example of luminescent rhenium complex used to stain a multicellular 
organism, opening the way to the development of no-radioactive derivatives as efficient phosphorescent probes suitable for cell 
imaging. 
 
Experimental 
 
Materials and methods 
Chemicals were purchased from commercial sources and used without further purification, unless otherwise indicated. When 
anhydrous conditions were required, the reactions were performed in oven-dried glassware under a nitrogen atmosphere. All the 
solvents were deoxygenated and dried using standard methods before use; toluene, Et2O and dioxane were distilled on Na(s), while 
CH2Cl2 on P2O5. Commercial deuterated solvents were used as received. Column chromatography was performed using Alfa Aesar 
silica gel 60 (0.032–0.063 mm). 1H NMR spectra were recorded on a Bruker DRX-400 MHz instrument, equipped with a Bruker 5 mm 
BBI Z-gradient probe head with a maxima gradient strength of 53.5 G cm-1. IR spectra in solution were acquired on a Bruker Vector 
22 FT spectrophotometer. Elemental analyses were performed on a Perkin Elmer CHN2400 instrument. ESI-MS spectra were acquired 
on LCQ Fleet ion trap mass spectrometer  (Thermo Fisher). Electronic absorption spectra were recorded on an Agilent Model 8543 
spectrophotometer at room temperature, and using quartz cells with a 1.0 cm path length.  
Synthesis 
Synthesis of the alkylated pyridazine ligands D1-D3. All the alkylated pyridazines were prepared according to a literature 
procedure,18  involving as first step the synthesis of 1,2,4,5-tetrazine (from hydrazine hydrate and formamidine acetate) and then its 
reaction with 17-ethynylestradiol for D1, hex-5-ynoic acid for D2 and undec-9-ynoic acid for D3 pyridazine ligand.  D1 and D2 were 
isolate as pure white solid by addition of Et2O or n-hexane to a concentrated CH2Cl2 solution of D1 and D2, respectively (isolated yield 
47% for D1 and 68% for D2).  D3 was not isolated as pure solid and was used in mixture with the corresponding alkyne. The purity of 
the ligands was checked by 1H-NMR spectroscopy. 3-(17-estradiol)pyridazine (D1): 1H NMR (Acetone-d6, 298 K): δ = 9.29 (1H, s, Ha 
pydz ), 9.13 (1H, d, Hb pydz ), 7.59 (1H, d, Hc pydz), 7.09 (1H, d, H4), 6.54 (2H, m, H1,H2 ), 4.67 (1H, s, 3-OH ), 2.81 (1H, m, H6), 2.5-2.0 
(3H, m, H11, H11, H12), 2.00-1.6 (5H, m, H9, H15, H15, H7, H16), 1.5-1.3 (4H, m, H8, H14, H7, H12), 1.15 (3H, CH3), 0.5 
(1H, m, H16) ppm. 8-(5-methhylpyridazine-4-yl)-octanoic acid (D3), 1H NMR (CD2Cl2, 298 K):   8.89 (s, 2H, Hortho accidental overlap), 
2.65 (pt, 2H, CH2-(CH2)5-CH2-COOH), 2.40 (t, J = 7.0, 2H, CH2-(CH2)5-CH2-COOH), 2.36 (s, 3H, CH3), 1.76-1.30 (m, 10H, CH2-(CH2)5-CH2-
COOH) ppm. 
 
Synthesis of the Complexes Re2, Re3 and Re-4Me. The complexes (see Schemes 3 for their structures and abbreviations) were 
prepared from [ReCl(CO)5], using the method previously reported.10a, 11a,19 The crude  products were purified by addition of n-hexane 
to a concentrated solution in CH2Cl2, affording pure yellow powders in high isolated yields (40–80%). [Re2(-Cl)2(CO)6(-4-(pyridazin-
4yl)-butanoic acid)] (Re2)11a: 1H NMR (CD2Cl2, 400 MHz, 298 K): δ = 9.68 (2H, m, Ha+Hb pydz ), 7.90 (1H, m, Hc pydz), 3.01 (2H, m, CH2-
CH2-CH2-COOH), 2.59  (2H, m, CH2-CH2-CH2-COOH), 2.14 (2H, m, CH2-CH2-CH2-COOH) ppm. FT-IR (CO) toluene: 2049 (m), 2033 (s), 
1947 (s), 1914 cm1. Anal. calcd for C14H10Cl2N2O8Re2: C 21.63, H 1.30, N, 3.60; found: C 21.40, H 1.41, N 3.56 [Re2(-Cl)2(CO)6(-8-(5-
methylpyridazin-4yl)-octanoic acid)] (Re3): 1H NMR (CD2Cl2, 400 MHz, 298 K): δ = 9.49 (1H, s, Ha), 9.45 (1H, s, Hb pydz), 2.86 (2H, m, 
CH2-COOH), 2.58  (3H, s, CH3), 2.39 (2H, m, pydz-CH2), 1.8-1.4 (10H, CH2 aliphatic chain). Anal. calcd for C19H20Cl2N2O8Re2: C 26.92, H 
2.38, N, 3.30; found: C 27.05, H 2.35, N 3.15 
[Re2(-Cl)2(CO)6(-4-methylpyridazine)] (Re-4Me)19: 1H-NMR:  2.68 (s, 3H, CH3), 7.86 (dd,1H), 9.64 (d, 1H, J = 5.8 Hz), 9.67 (d, J =1.3 
Hz, 1H).FT-IR (CO) = 2050 (m), 2034 (s), 1947 (s), 1915 cm1 (s). Anal. calcd for C11H6Cl2N2O6Re2: C 18.73, H 0.86, N 3.97; found: C 
19.08, H 0.79, N 4.05 
 
Synthesis of the 4-(17-ethynylestradiol)aniline (E0). 17-ethynylestradiol (300 mg, 1.01 mmol) was added as a solid to a solution 
Pd(PPh3)2Cl2 (28 mg, 4 mol %), and CuI (15.4 mg, 8 mol %) in 25 mL CH2Cl2 and 5 ml of triethylamine (TEA) under an inert atmosphere 
of nitrogen. The solution was stirred at room temperature for ten minutes. 4-iodo-anilina (221.6 mg, 1.012 mmol) was dissolved in 4 
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ml of CH2Cl2 under an inert atmosphere of nitrogen at room temperature and then slowly added to the solution containing the 17-
ethynylestradiol.  The color of the mixture turned to yellow after three hours and the mixture was then  stirred for 24 h. The solid 
waste removed by filtration and, after the extraction with CH2Cl2, the organic phase was washed with small amount of NH4Cl, brine 
and water and evaporated to dryness. The crude product was therefore purified by column chromatography on silica gel 
(CH2Cl2/AcOEt = 9/1) affording E0 as pale yellow solid. Yield: 276 mg (70%). 1H NMR (CD2Cl2, 400 MHz, 298 K): δ = 7.94 (1H, d, H1 
estradiol), 7.14 (2H, d, Hb+Hb’), 6.62 (3H, m, Ha+Ha’ and H2 estradiol), 6.54 (1H, H4 estradiol), 4.91 (1H, s, 3-OH ), 4.27 (2H, NH2), 2.77 
(2H, m, H6), 2.4-2.15 (3H, m, H11, H9, H12), 2.10-1.70 (6H, m, H14, H15, H7, H16, H16, H11), 1.5-1.3 (3H, m, H8, H12, 
H7), 0.95 (3H, CH3) 
 
Synthesis of [Re2(-Cl)2(CO)6(-3-(17-estradiol)pyridazine)] (E2-Re1). The complexes E2-Re1 was prepared from [ReCl(CO)5], using 
the method previously reported,10 in the presence of 0.5 equivalents of pyridazine ligand D1, in toluene solution. The crude product 
was purified by column chromatography on silica gel (AcOEt/n-hexane = 1/1), affording a pure yellow powder (19.3 mg, isolated yield 
36%).  1H NMR (CD2Cl2, 400 MHz, 298 K): δ = 9.90 (1H, s, Ha pydz ), 9.72 (1H, d, Hb pydz ), 7.87 (1H, d, Hc pydz), 7.09 (1H, d, H1), 6.57 
(2H, m, H2,H4 ), 4.71 (1H, s, 3-OH ), 2.86 (2H, m, H6), 2.55-2.2 (3H, m, H11, H11, H12), 2.10-1.75 (5H, m, H9, H15, H15, H7, 
H16), 1.6-1.3 (4H, m, H8, H14, H7, H12), 1.22 (3H, CH3), 0.62 (1H, m, H16) ppm.  FT-IR (CO) toluene: 2051 (m), 2034 (s), 1949 
(s), 1917 cm1. ESI-MS: m/z 959.39 [M-2CO]+ Anal. calcd for C30H26Cl2N2O8Re2: C 34.96, H 2.72, N, 2.91; found: C 34.90, H 3.01, N 2.63. 
 
Synthesis of [Re2(-Cl)2(CO)6(-4-(pyridazin-4yl)-butanoic-E0 amide)] (E2-Re2). A solution containing the complex Re2 (20 mg, 
0.0257 mmol),  HATU (12.07 mg, 0.0308 mmol) and HOBt (4.28 mg, 0.0308 mmol) in 1 ml of CH2Cl2 and 5.38 μL (0.0358 mmol) of TEA 
and 100 μL di AcOEt was stirred at room temperature for 10 minutes. Then 19 mg (0.0514 mmol) of estradiol precursor E0 and 7.17 
μL (0.0514 mmol) of TEA were added. The reaction was stirred at room temprature for 24 hours and therefore it was evaporated to 
dryness under reduced pressure to give a yellow solid. The crude product was purified by column chromatography on silica gel 
(CH2Cl2/ AcOEt = 7/3) affording 14.8 mg of isolated pure powder (50.2%). 1H NMR (CD2Cl2, 400 MHz, 298 K): δ = 9.70-9.69 (2H, m, 
Hc+Hd pydz),  7.95 (1H, m, He pydz), 7.36 (1H, d, H1 estradiol), 7.26 (2H, dd, Hb+Hb’), 6.87 (1H, m, H2 estradiol), 6.83 (1H, m, H4 
estradiol), 6.64 (2H, dd, Ha+Ha’), 3.90 (1H, broad, 3-OH ), 3.07 (2H, m, CH2-CH2-CH2-COOH), 2.90 (2H, m, H6), 2.77  (2H, m, CH2-CH2-
CH2-COOH), 2.48-2.27 (3H, m, H11, H9, H12), 2.21 (2H, m, CH2-CH2-CH2-COOH), 2.15-1.75 (7H, m, H14, H15, H15, H7, H16, 
H16, H11), 1.5-1.35 (3H, m, H8, H12, H7), 0.95 (3H, CH3) ppm. FT-IR (CO) CH2Cl2: 2047 (m), 2032 (s), 1948 (s), 1916 cm1. Positive 
ion ESI-MS: m/z = 1146.24 [M]+. Anal. calcd for C40H37Cl2N3O9Re2: C 41.88, H 3.25, N, 3.66; found: C 41.80, H 3.36, N 3.54. 
 
Synthesis of [Re2(-Cl)2(CO)6(-8-(5-methylpyridazin-4yl)-octanoic-E0 amide)] (E2-Re3). A solution containing the complex Re3 (30 
mg, 0.0353 mmol),  HATU (16.60 mg, 0.0423 mmol) and HOBt (5.89 mg, 0.0423 mmol) in 2 ml of CH2Cl2 and 7.44 μL (0.0529 mmol) 
of TEA and 200 μL di AcOEt was stirred at room temperature for 10 minutes. Then 27.42 mg (0.0707 mmol) of estradiol precursor E0 
and 9.93 μL (0.0707 mmol) of TEA were added. The reaction was stirred at room temprature for 24 hours and therefore it was 
evaporated to dryness under reduced pressure to give a yellow solid. The crude product was purified by column chromatography on 
silica gel (CH2Cl2/ AcOEt = 7/3) affording 12.1 mg of isolated pure powder (28%). 1H NMR (CD2Cl2, 400 MHz, 298 K): δ = 9.49 (1H, s, Hc 
pydz),  9.45 (1H, s, Hd pydz), 7.34 (1H, d, H1 estradiol), 7.26 (2H, dd, Hb+Hb’), 6.83 (1H, m, H2 estradiol), 6.79 (1H, m, H4 estradiol), 
6.64 (2H, m, Ha+Ha’), 3.90 (1H, broad, 3-OH ), 2.87 (4H, m, -CH2-COOH and  H6 estradiol), 2.59-2.57 (5H, m, CH3 and CH2 alpihatic 
chain), 2.50-2.25 (3H, m, H11, H9, H12), 2.17-1.90 (3H, m, H12, H16, H11), 1.85-1.67 (5H, m, H14, H15, H15, H16, H7), 
1.6-1.20 (14H, m, H8, H7, and 10H of CH2 aliphatic chain), 0.95 (3H, CH3)  ppm. FT-IR (CO) CH2Cl2: 2045 (m), 2034 (s), 1948 (s), 1915 
cm1. ESI-MS: m/z 1215.60 [M]+. Anal. calcd for C45H47Cl2N3O9Re2: C 44.40, H 3.89, N 3.45; found: C 44.46, H 3.99, N 3.37. 
 
Photophysical characterization  
Photophysical measurements were carried out in air-equilibrated and de-areated toluene solutions at room temperature. Electronic 
absorption spectra were recorded on an Agilent Model 8543 spectrophotometer at room temperature, using quartz cells with 1.0 
cm path length. Steady-state emission spectra were recorded on an Edinburgh FLS980 spectrometer equipped with a 450 W ozone-
free xenon arc lamp, double grating excitation and emission monochromators (2300 mm focal length) and a Hamamatsu R928P 
photomultiplier tube. Time-resolved measurements were performed using the timecorrelated single-photon counting (TCSPC) option 
on the FLS980. The excitation sources were mounted directly on the sample chamber and the emission is collected by a multichannel 
plate MCP-PMT Hamamatsu H10720-01 single-photon-counting detector. The photons collected at the detector were correlated by 
a time-to-amplitude converter (TAC) to the excitation pulse. The data analysis was performed using the commercially available F980 
software (Edinburgh Instruments). The goodness of the data fitting was assessed by minimizing the reduced chi-squared function (2). 
Photoluminescence quantum yields () were collected on optically diluted solution (<1.0  105 M) using wavelength scanning with a 
Hamamatsu C11347-11 Quantaurus-QY Absolute PL quantumyield spectrometer, equipped with a xenon light source (150 W), a 
monochromator, a Spectralon integrating sphere, and employing the commercially available U6039-05 PLQY measurement software 
(Hamamatsu Photonics Ltd, Shizuoka, Japan). The photoluminescence quantum yields were measured exciting the samples between 
380–420 nm. 
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 Cell cultures 
MCF7 (human breast adenocarcinoma, cod. 86012803, Sigma Aldrich) cells were grown in  basal growth medium as following: 
minimum essential medium Eagle (EMEM) with Earles salts and NaHCO3, (Sigma) supplemented with 10% fetal calf serum 
(Euroclone), 2 mM glutamine (Euroclone), antibiotic antimycotic solution 100 U/mL penicillin, 100 µg/mL streptomycin and 0.25 
µg/mL amphotericin B (Sigma-Aldrich)  at 37°C, 5% CO2.  
 
Cell culture testing 
Cellular uptake of the three different complexes (E2-Re1, E2-Re2, E2-Re3) was investigated by using MCF7 breast cancer cells. Cells 
were seeded in 24x multiwells 4-5 days before the exposure experiments (cell density approximately 50000 cells/plate) and were 
cultivated (37°C, 5% CO2) in basal growth medium (see Cell culture paragraph). Three different concentrations (10, 30, 50 µM) and 
time-points (30’, 60’, 120’) were tested for each compound (in E2-Re3 the 10 µM was omitted). For the receptor targeting (specificity) 
tests, in parallel to E2-Re1 (50 µM, 30’), also estradiol-free rhenium complex [Re2(µ-Cl)2(CO)6(µ-4Me-pydz)] (Re-4Me) and a mixture 
of E2-Re1 (50 µM) and pure E2 (500 µM) were tested. All the Experiments were carried out in triplicates. The compounds were initially 
dissolved in DMSO and then added to serum-free EMEM (final DMSO concentration 1%). One mL of this solution was added to each 
well after removal of the serum-containing medium. At the end of the exposure period cells were washed with PBS and fixed with 
paraformaldehyde 4% for ten minutes. After further washings in PBS cells were mounted with Pro-long anti-fade reagent (P7481, Life 
Technologies) with DAPI to stain the nuclei. The images were acquired with a Leica TCS NT confocal microscope. 
Cells were imaged by excitation at 405 nm and the resulting emissions were collected in three different spectral interval (485/30, 
535/50, 600/40). 
 
C. intestinalis testing 
E2-Re1 uptake was investigated also in more complex biological systems i.e. multicellular organism (Ciona intestinalis embryos). 
Adults of C. intestinalis were collected by the fishing service of the Roscoff Biological Station (France). Animals were maintained in 
aquaria filled with artificial seawater (Instant Ocean; salinity about 32‰) and provided with circulation system as well as mechanical, 
chemical and biological filters. Constant light condition was preferred to promote gamete production. Gametes were obtained 
surgically from the gonoducts and dechorionated in filtered artificial seawater (ASW; pH 8.0) containing 1% sodium thioglycolate and 
0.05% protease. In vitro cross-fertilization was performed and embryos were cultured in 1% agarose-coated petri dish in ASW at 18 
°C up to the stages of interest. Embryos were exposed to 20 µM E2-Re1 for 3 h: to obtain samples at 76-cell stage (4.2 hour post 
fertilization (hpf); Hotta et al., 2007) exposure period started at 4-cell stages (1.45 hpf) while late tailbud embryos (13 hpf) were 
exposed at mid tailbud stage (10 hpf). Embryos were then fixed with 4% Paraformaldehyde in PBS, mounted with 1,4-
diazabicyclo[2,2,2]octane (DABCO, Sigma, Italy) on microscope slides and observed under a Leica TCS SP2 Laser Scanning Confocal 
microscope (Leica Microsystems) as above described. 
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